Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

0.4780
+0.01803.91%
Post-market: 0.47800.00000.00%16:19 EDT
Volume:657.30K
Turnover:309.56K
Market Cap:141.12M
PE:-0.36
High:0.4890
Open:0.4890
Low:0.4550
Close:0.4600
Loading ...
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K/A [Amend] - Current report
Sep 30, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence